Cargando…
Fibroblast Growth Factor–23 and Cardiac Structure and Function
BACKGROUND: Fibroblast growth factor–23 (FGF‐23) is a phosphaturic factor previously associated with left ventricular hypertrophy and systolic dysfunction among individuals with chronic kidney disease. Whether FGF‐23 acts directly to induce left ventricular hypertrophy, potentially independent of it...
Autores principales: | Agarwal, Isha, Ide, Noriko, Ix, Joachim H., Kestenbaum, Bryan, Lanske, Beate, Schiller, Nelson B., Whooley, Mary A., Mukamal, Kenneth J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3959672/ https://www.ncbi.nlm.nih.gov/pubmed/24525546 http://dx.doi.org/10.1161/JAHA.113.000584 |
Ejemplares similares
-
Elevated Fibroblast Growth Factor 23 Levels Are Associated With Greater Diastolic Dysfunction in ESRD
por: Sharma, Shilpa, et al.
Publicado: (2019) -
Insulin Resistance, Cystatin C, and Mortality Among Older Adults
por: de Boer, Ian H., et al.
Publicado: (2012) -
Fibroblast growth factor 23 and cognitive impairment: The health, aging, and body composition study
por: Drew, David A., et al.
Publicado: (2020) -
Fibroblast Growth Factor‐23 and Heart Failure With Reduced Versus Preserved Ejection Fraction: MESA
por: Almahmoud, Mohamed Faher, et al.
Publicado: (2018) -
Potassium Measures and Their Associations with Glucose and Diabetes Risk: The Multi-Ethnic Study of Atherosclerosis (MESA)
por: Chatterjee, Ranee, et al.
Publicado: (2016)